北美的AI支援醫療影像市場

North America AI-assisted Medical Imaging Market

出版日期: 2025年09月04日 | 出版商:

Marketstrat, Inc. | 英文 54 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

調查範圍

國家美國，加拿大
模式CT，MRI，X光/DR，超音波，PET/核醫學
臨床領域腫瘤學，神經學/中風，心臟病，呼吸系統/肺，MSK/整形，一般
用途分診→檢測→重組→整合
收益的流程硬體設備，軟體，服務，雲端/利用費用制
最終用途醫院/IDN，影像診斷中心，診所，遠隔放射線醫療，其他.(章節2，目的和範圍)

研究方法

雙視角方法：自上而下分析北美藥品總數及各國具體比例；自下而上分析原廠安裝和改造組合、平均售價區間以及各北美藥品特定證據權重（FDA/加拿大衛生部）。根據節奏、報銷訊號、企業採購和真實世界數據 (RWE)，按模式劃分的依從性推動因素。

報告概述

發展軌跡：到 2032 年，北美市場規模將擴大至 132 億美元（複合年增長率 30%）（摘要整理，第 10 頁；表 1，第 14 頁）。
沾黏餘量：OEM 的 AI 將安裝在 20% 的新 CT 和 15% 的新 MR 樣本跑道中，包括超音波和 PET。（包裝說明書定價討論和圖 3，第 18-19 頁。）

推動數位成長的因素

降低報銷額：得益於 CMS 的 NTAP 更新（卒中 AI）以及用於 CT-FFR、迴聲失真和乳腺 AI 的新 CPT 堆棧，美國繼續佔主導地位，其增長速度約為加拿大的 9 倍。
企業購買力：美國大型 IDN 已獲得多年的 "AI 商店" 許可證，支出擴張速度快於基本掃描的成長速度。
監管澄清：FDA 的 "預定變更控制計畫" 草案允許演算法升級無需重新提交，從而縮短了更新周期並提高了平均回報率 (ARR)。
加拿大迎頭趕上：單一支付州正在謹慎行事，但全國範圍內的肺癌篩檢試點和針對 CADTH 特異性結核病 AI 的 HTA 正在推動其應用。雖然複合年增長率低至 29%，但市場規模每三年仍翻倍。
跨國供應商：如果美國雲端 AI 供應商能夠證明其隱私合規性（PIPEDA/HIPAA），則更有可能贏得加拿大的競標，從而進一步縮小差距。

報告優勢

切入點/取勝之道 NAGTM 成長與成熟度矩陣、競爭資料集、監管速度與併購觀察名單。（圖表，第 15-18 頁）。
國家策略手冊：美國和加拿大 GTM 雷達、渠道/定價矩陣、客戶潛力以及包含 12 個月行動提示的時間表。（美國，第 31-38 頁，加拿大，第 52-54 頁）。
預測深度：依國家、治療模式、臨床領域、應用、收入來源和最終用途細分，直至 2032 年。（表格請參閱第 24-30 頁及第 43-51 頁。）

市場摘要-美國
市場概要-美國
- 人口統計與流行病學
- 宏觀經濟與醫療保健支出
- 影像數量和安裝基數
- 監理與報銷概況
- 醫療保健服務與實踐模式
- AI 市場動態（影像）
- 競爭格局
- 供應商經驗教訓
以臨床領域劃分的美國市場
以影像模式劃分的美國市場
以收入來源劃分的美國市場
以臨床應用劃分的美國市場
以最終使用機構劃分的美國市場
以 AI 技術劃分的美國市場
Ma Markintel 成長成熟度矩陣 - 美國和加拿大
Markintel 解採用和成長矩陣 - 美國和加拿大
Markintel 生態系協作矩陣 - 美國與加拿大
GTM 概覽 - 美國

章節5-加拿大市場

市場摘要:加拿大
市場概要-加拿大
各臨床領域加拿大市場
加拿大市場，各臨床領域
加拿大市場，影像診斷法
加拿大市場，不同收益來源
加拿大市場，各臨床用途
加拿大市場，各最終用途組織
加拿大市場，各AI技術
GTM概要- 加拿大

簡介目錄圖表

Product Code: MINTP-M01120

Report Scope

Countries: United States, Canada
Modalities: CT, MRI, X ray/DR, Ultrasound, PET/Nuclear
Clinical Areas: Oncology, Neurology/Stroke, Cardiology, Respiratory/Lung, MSK/Ortho, General
Applications: Triage -> detection -> reconstruction -> integration
Revenue Streams: Hardware, Software, Services, Cloud/Pay per Use
End use: Hospitals/IDNs, Imaging Centers, Clinics, Teleradiology, Other. (Section 2, Objective & Scope.)

Methodology

Dual lens approach: top down reconciliation to NA totals and country splits; bottom up attach rate engine by modality with factory vs retrofit mixes, ASP bands, and NA specific evidence weights (FDA/Health Canada cadence, reimbursement signals, enterprise buying, and RWE).

Report Snapshot

Trajectory: North America expands to ~US$13.2B by 2032 (~30% CAGR) . (Executive Summary, p.10; Table 1, p.14.)
Attach rate headroom: OEM AI ships on ~20% of new CT and ~15% of new MR-ample runway across ultrasound and PET. (Attach rate discussion & Figure 3, pp.18-19.)

What's Driving the Numbers

Reimbursement pull: The U.S. continues to dominate-about 9-to-1 versus Canada-thanks to CMS NTAP renewals (stroke AI) and the emerging CPT stack for CT-FFR, echo strain and breast-AI.
Enterprise buying power: Large U.S. IDNs lock multi-year "AI-store" licenses, scaling spend faster than underlying scan growth.
Regulatory clarity: FDA's Predetermined Change-Control Plan draft allows algorithm upgrades without re-filing, shortening refresh cycles and feeding ARR.
Canada's catch-up: Single-payer provinces move more cautiously, but national lung-cancer screening pilots and CADTH's positive HTA for TB AI push adoption. The lower 29 % CAGR still doubles market size every three years.
Cross-border vendors: U.S. cloud-AI providers increasingly win Canadian tenders once privacy compliance (PIPEDA/HIPAA) is proven, further narrowing the gap.

Report Benefits

Where to play / how to win: NA GTM Growth & Maturity Matrix, competitive dataset, regulatory velocity, and M&A watchlist. (Figures & tables, pp.15-18.)
Country playbooks: U.S. & Canada GTM radars, channel/pricing matrices, customer tier potential, and timelines with 12 month action cues. (U.S. pp.31-38; Canada pp.52-54.)
Forecast depth: Breakouts by country, modality, clinical area, application, revenue stream, and end use through 2032. (Tables across pp.24-30, 43-51.)

SECTION 1 - EXECUTIVE SUMMARY

25 second Read
Size & Trajectory
Modality & Attach rate Dynamics
Buyer & Route to Market
Competitive Temperature
What to do in the Next 12 Months

SECTION 2 - RESEARCH METHODOLOGY

Objective & Scope
Dual lens Architecture
North America-specific Evidence Stack & Weights
Calibration Choices (NA)

SECTION 3 - NORTH AMERICAN MARKET

Market Summary
- Market Size & Drivers
- Latest Trends
- Strategic Outlook
- Competitive Environment
- New Focus Areas
North American Market Estimates & Forecasts (2023-2032)
- AI Imaging Market by Country - North America
- What's Driving the Numbers
- Implications
Markintel GTM Growth and Maturity Matrix - North America
- Competitive Dataset - North America
- Competitive Context - North America AI-Imaging 2024
- Strategic Takeaways
- Growth & Maturity Highlights - North America
- M&A Watchlist - North America Rising Stars
Regulatory Velocity - North America
OEM AI Attach-Rate by Modality
- Attach Rate Trends - North America
- Factory vs Retrofit - North America

SECTION 4 - UNITED STATES MARKET

Market Summary - United States
- Key Market Dynamics
- Strategic Takeaways
- Top 3 Recommendations
Market Overview - United States
- Demographics & Epidemiology
- Macro economics & Health Spending
- Imaging Volume & Installed Base
- Regulatory & Reimbursement Snapshot
- Healthcare Delivery & Practice Patterns
- AI Market Dynamics (Imaging)
- Competitive Landscape
- Takeaways for Vendors
US Market by Clinical Area
- Forecast by Clinical Area (2023-2032, USD Mill)
- U.S. AI-Imaging Outlook by Clinical Area (2023 -> 2032)
- Key Dynamics to Watch
- Implications for Vendors
US Market by Imaging Modality
- Forecast by Modality (2023-2032, USD Mill)
- U.S. Modality Outlook: Who Grows, Who Overtakes
- Key Takeaways
US Market by Revenue Stream
- Forecast by Revenue Stream (2023-2032, USD Mill)
- U.S. Revenue Stream Shift: From Capital Boxes to Recurring Bytes
- What's Driving the Mix Change
- Implications for Vendors
US Market by Clinical Application
- Forecast by Clinical Application (2023-2032, USD Mill)
- Outlook by Clinical Application
- Highlights
- Implications
US Market by End-Use Organization
- Forecast by End-Use Organization (2023-2032, USD Mill)
- Who Buys AI-and How That Mix Shifts Through 2032
- What's Behind the Shift
- Strategic Implications for Vendors
US Market by AI Technology
- Forecast by AI Technology (2023-2032, USD Mill)
- Outlook by Core Technology (2023-2032)
Markintel Growth Maturity Matrix - US & Canada
- Competitive Dataset - United States
- Competitive Context - U.S./North America
- What to Watch Next
Markintel Solution Adoption & Growth Matrix - US & Canada
- Scorecard - Solution Adoption & Growth Matrix (U.S. & Canada)
- Strategic Implications for Stakeholders
Markintel Ecosystem Collaboration Matrix - US & Canada
- Who to Partner with and How Deep?
- What Succeess Looks Like in Each Quadrant
- Stratregic Guidance
GTM at a Glance - United States
- Channel & Pricing Matrix
- GTM Readiness Radar - US
- Customer Tier Potential - US
- GTM Timeline (2025-2028) - US
- Fast Strategic Cues (2025)
- Regulatory x Funding Heatmap - US
- Adjacency-Opportunity Radar - US
- Whitespace Partner-Fit Matrix - US

SECTION 5 - CANADIAN MARKET

Market Summary: Canada
- Key Market Dynamics
- Strategic Takeaways
- Top 3 Recommendations
Market Overview - Canada
- Demographics & Epidemiology
- Imaging Supply & Utilization
- Health System & Practice Patterns
- Regulatory & Reimbursement
- AI-Imaging Market Dynamics
- Competitive Snapshot
- Key Implications
Canadian Market by Clinical Area
- Forecast by Clinical Area (2023-2032, USD Mill)
- Outlook by Clinical Area
- Key Dynamics to Watch
- Implications for Vendors
Canadian Market by Imaging Modality
- Forecast by Imaging Modality (2023-2032, USD Mill)
- Outlook by Modality
- Key Dynamics to Watch (2025-27)
- Implications for Vendors
Canadian Market by Revenue Stream
- Forecast by Revenue Stream (2023-2032, USD Mill)
- What's Driving Each Revenue Stream
- Key Dynamics to Watch
- Implications for Vendors
Canadian Market by Clinical Application
- Forecast by Clinical Application (2023-2032, USD Mill)
- Outlook & Drivers by Application
- Key Market Dynamics to 2027
- Implications for Vendors and Providers
Canadian Market by End-Use Organization
- Forecast by End-Use Organization (2023-2032, USD Mill)
- Outlook 2025-2032
- Key Drivers by Segment
- Implications for Vendors
- Strategic Takeaways
Canadian Market by AI Technology
- Forecast by AI Technology (2023-2032, USD Mill)
- Highlights by Technology
- Key Dynamics to Watch (2025 27)
- Implications for Vendors & Providers
GTM at a Glance - Canada
- GTM Readiness Radar - Canada
- Tiered Customer Landscape
- Channel & Pricing Matrix
- GTM Timeline (Canada)
- Fast Cues for 2025 Stakeholders